Beryl Drugs Limited (BERLDRG) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE415H01017
Key metrics
- Market Cap
- ₹12 Cr
- P/E Ratio
- 18.48
- EPS
- 1.24
- Book Value
- 19.5
- P/B Ratio
- 1.18
- ROE
- 4.3%
- ROCE
- 7.56%
- Debt / Equity
- 0.25
- Net Margin
- 2.26%
- Revenue Growth
- -11%
- Profit Growth
- -25.15%
- Dividend Yield
- —
- 52W High
- ₹27.60
- 52W Low
- ₹15.92
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Beryl Drugs Limited
Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.
- Headquarters
- Indore, India
- Promoter Holding
- 40.48%
The full Beryl Drugs Limited analysis
Create a free account to open the complete BERLDRG deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.